Plasma corticotrophin releasing hormone, vasopressin, ACTH and Cortisol responses to acute myocardial infarction
Authors:
- 1 April 1994
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 40 (4) , 499-504
Abstract
Summary: OBJECTIVES We assessed the magnitude and duration of the response of hypothalamic‐pituitary‐adrenal hormones to the stress of myocardial infarction, in the presence and absence of angiotensin converting enzyme inhibitors. In particular, we wished to analyse the interrelationships between peripheral plasma levels of corticotrophin releasing hormone (CRH), vasopressin (AVP) and adrenocorticotrophin (ACTH), and also between ACTH and Cortisol, during a prolonged medical stress.DESIGN All hormones were measured within 6 hours of the onset of an acute myocardial infarction. Patients were randomly allocated to three different study groups according to a double blind procedure.PATIENTS Group 1 (10 patients) received placebo treatment, Group 2 (13 patients) received a maintenance dose of captopril 25 mg three times daily, Group 3 (11 patients) received enalapril 5 mg three times daily.MEASUREMENTS Peptide hormones were measured by radioimmunoassay, and Cortisol by ELISA. Reference ranges for all hormones were obtained from 40 or more volunteers from the electoral roll.RESULTS At the start of the study, mean±SEM plasma AVP (27.9 ± 4.6 pmol/l) was significantly (P50 pmol/l. Mean plasma Cortisol (960 ± 89.6 nmol/l) was also raised above the reference range mean (554±28 nmol/l, PPPPPCONCLUSIONS Within 6 hours of a myocardial infarction, mean plasma CRH, AVP and Cortisol values were very significantly raised above mean control values, while ACTH was very significantly reduced. During the 3 days following an acute myocardial infarction, plasma CRH, AVP and Cortisol fell substantially, and this pattern was not influenced by angiotensin converting enzyme inhibitors. By contrast, plasma ACTH showed a significant increase with time. This suggests that the usual relationships between CRH, AVP and ACTH, and between ACTH and Cortisol are disturbed in patients admitted to hospital with myocardial infarction. Maximum levels of AVP observed in 12 patients exceeded 50 pmol/l, which may be sufficiently high to interfere with tissue perfusion. It is postulated that V1, AVP receptor antagonists may have a therapeutic application in limiting infarct size.Keywords
This publication has 28 references indexed in Scilit:
- Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the “practical” Study)The American Journal of Cardiology, 1994
- The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomyClinical Endocrinology, 1993
- Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullarisEndocrinology, 1992
- Production of a monoclonal antibody to cortisol: Application to a direct enzyme-linked immunosorbent assay of plasmaSteroids, 1992
- The hunt for the CIA: factors which demonstrate corticotrophin-inhibitory activityJournal of Endocrinology, 1989
- Cortisol level predicts myocardial infarction in patients with ischaemic chest painInternational Journal of Cardiology, 1989
- AUGMENTATION OF THE RESPONSE TO CRF IN MAN: RELATIVE CONTRIBUTIONS OF ENDOGENOUS ANGIOTENSIN AND VASOPRESSINClinical Endocrinology, 1985
- Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.Journal of Clinical Investigation, 1983
- Corticotropin releasing activity of the new CRF is potentiated several times by vasopressinNature, 1982
- OPIATES CONTROL ACTH THROUGH A NORADRENERGIC MECHANISMClinical Endocrinology, 1982